Education
About Us
Working with TipRanks
Follow Us
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
GLAXO Stock Chart & Stats
Day’s Range― - ―
52-Week Range₹1,825.05 - ₹3,087.95
Previous CloseN/A
Volume25.42K
Average Volume (3M)N/A
Market Cap
₹419.20B
Enterprise Value₹445.72B
Total Cash (Recent Filing)₹987.77M
Total Debt (Recent Filing)₹5.83M
Price to Earnings (P/E)48.8
Beta0.45
Next Earnings
May 14, 2025EPS EstimateN/A
Last Dividend Ex-Date
Nov 07, 2024Dividend Yield1.29%
Share Statistics
EPS (TTM)50.72
Shares Outstanding169,406,040
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹2,250.00Price Target Upside-9.07% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
GLAXO FAQ
What was GlaxoSmithKline Pharmaceuticals Limited’s price range in the past 12 months?
GlaxoSmithKline Pharmaceuticals Limited lowest stock price was ₹1825.05 and its highest was ₹3087.95 in the past 12 months.
What is GlaxoSmithKline Pharmaceuticals Limited’s market cap?
GlaxoSmithKline Pharmaceuticals Limited’s market cap is ₹419.20B.
When is GlaxoSmithKline Pharmaceuticals Limited’s upcoming earnings report date?
GlaxoSmithKline Pharmaceuticals Limited’s upcoming earnings report date is May 14, 2025 which is in 72 days.
How were GlaxoSmithKline Pharmaceuticals Limited’s earnings last quarter?
GlaxoSmithKline Pharmaceuticals Limited released its earnings results on Feb 14, 2025. The company reported ₹13.6 earnings per share for the quarter, beating the consensus estimate of N/A by ₹13.6.
Is GlaxoSmithKline Pharmaceuticals Limited overvalued?
According to Wall Street analysts GlaxoSmithKline Pharmaceuticals Limited’s price is currently Overvalued.
Does GlaxoSmithKline Pharmaceuticals Limited pay dividends?
GlaxoSmithKline Pharmaceuticals Limited pays a Annually dividend of ₹12 which represents an annual dividend yield of 1.29%. See more information on GlaxoSmithKline Pharmaceuticals Limited dividends here
What is GlaxoSmithKline Pharmaceuticals Limited’s EPS estimate?
GlaxoSmithKline Pharmaceuticals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlaxoSmithKline Pharmaceuticals Limited have?
GlaxoSmithKline Pharmaceuticals Limited has 169,406,040 shares outstanding.
What happened to GlaxoSmithKline Pharmaceuticals Limited’s price movement after its last earnings report?
GlaxoSmithKline Pharmaceuticals Limited reported an EPS of ₹13.6 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.107%.
Which hedge fund is a major shareholder of GlaxoSmithKline Pharmaceuticals Limited?
Currently, no hedge funds are holding shares in IN:GLAXO
---
GLAXO Stock 12 Month Forecast
Average Price Target
₹2,250.00
▼(-9.07% Downside)
Technical Analysis
Aurobindo Pharma Ltd
―
Biocon Limited
―
Cipla Ltd
―
Dr. Reddy's Laboratories Ltd.
―
Sun Pharmaceutical Industries Limited
―
Best Analysts Covering GLAXO
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+6.10%
upgraded a buy rating 15 days ago
Copying Abdulkader Puranwala's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +6.10% per trade.
---